Characteristics of cutaneous anthrax in Turkey

Journal of Infection in Developing Countries

Volumn 3, Issue 8, 2009, Pages 599-603

  Baykam, Nurcan ^a   Ergonul, Onder ^b   Ulu, Aysegul ^a   Eren, Sebnem ^a   Celikbas, Aysel ^a   Eroglu, Mustafa ^a   Dokuzoguz, Basak ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Cutaneous anthrax; Turkey

Indexed keywords

CIPROFLOXACIN; IMIPENEM; PENICILLIN G; PROCAINE PENICILLIN; STEROID; SULTAMICILLIN; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ADULT; AGRICULTURAL WORKER; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BACTERIAL SUPERINFECTION; CELLULITIS; DIFFERENTIAL DIAGNOSIS; EDEMA; ESCHERICHIA COLI; FEMALE; GRAM STAINING; HUMAN; INCUBATION TIME; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PUBLIC HEALTH PROBLEM; SPHINGOMONAS PAUCIMOBILIS; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC); ULCER; ZOONOSIS; DEVELOPING COUNTRY; DRUG COMBINATION; INCIDENCE; MIDDLE AGED; PATHOLOGY; STAINING;

ANIMALIA; BACILLUS ANTHRACIS;

ANTHRAX; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PENICILLINS; SKIN DISEASES, BACTERIAL; STAINING AND LABELING; TURKEY;

EID: 73349107493     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.551     Document Type: Article

References (14)

1. Dixon TC, Meselson M, Guillemin J, Hanna PC (1999) Anthrax. N Engl J Med 341: 815-826.
2. Lucey D (2005) Bacillus anthracis(Anthrax). In:Mandell GL, Bennett JE, Dolin R (eds) Principles and Practice of Infectious Diseases (6th ed.) Churchill Livingstone, Pennsylvania, 2485-2491.
3. Öncül O, Özsoy MF, Gül HC, Koçak N, Çavu?lu S, Pahsa A (2002) Cutaneous Anthrax in Turkey: A Review of 32 Cases. Scand J Infect Dis. 34: 413-416.
4. Demirdaǧ K, Özden M, Saral Y, Kalkan A, Kiliç SS, Özdarendeli A (2003) Cutaneous Anthrax in Adults: A review of 25 cases in the Eastern Anatolian Region of Turkey. Infection 31: 327-330.
5. Çaksen H, Arabaci F, Abuhandan M, Tuncer O, Cesur Y (2001) Cutaneous Anthrax in Eastern Turkey. Cutis 67: 488-492.
6. Irmak H, Buzgan T, Karahocagil MK, Sakarya N, Akdeniz H, Caksen H, Demiroz P (2003) Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases. Med Sci Monit 9: RA276-83.
7. Anthrax in Humans and Animals. Turnbull P (ed) WHO Library Cataloguing-in-Publication Data 4th ed. 2008.
8. Centers for Disease Control and Prevention (2001) Update:investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001,MMWR 50:909-919.
9. Swartz MN (2001) Recognition and management of anthrax: an update. N Engl J Med 345: 1621-1626.
10. Bakici MZ, Elaldi N, Bakir M, Dokmetas I, Erandac M, Turan M (2002) Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Scand J Infect Dis 34: 564-566.
11. Doǧanay M and Aydin N (1991) Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 23: 333-335.
12. Bradaric N and Punda-Polic V (1992) Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite. Lancet 340: 306-307.
13. Swartz MN (2001) Recognition and management of anthrax: an update. N Engl J Med 345: 1621-1626.
14. Esel D, Doganay M, Sumerkan B (2003) Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Int J Antimicrob Agents 22:70-72.